Subcutaneous Drug Development & Delivery Consortium Inc

High dose high volume: published "towards more tolerable subcutaneous administration: review of contributing factors for improving combination product design," drafted an industry-wide survey and established a framework for a publication on the hdhv integrated roadmap, and finalized a survey and framework for a publication on the harmonization of pain scoring in sc clinical trials.

Clinical development & regulatory strategy: presented at the crs annual meeting on debunking myths of sc delivery, executed a survey regarding clinical development and regulatory strategies for high-dose biologics, and completed writing of a manuscript based on the survey results, with submission expected by the end of the year.